These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
|
|||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
|
|||||||
(Address of principal executive offices) | (Zip Code) |
(
|
||||||||
(Registrant's telephone number, including area code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
ý | Accelerated Filer | ☐ | |||||||||||||||||
Non-accelerated Filer | ☐ | Smaller Reporting Company |
|
|||||||||||||||||
Emerging Growth Company |
|
Page | ||||||||
Assets |
March 31,
2025 |
December 31,
2024 |
|||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ |
|
|
||||||||
Trade accounts receivable, net of allowance for credit losses of $
|
|
|
|||||||||
Inventories |
|
|
|||||||||
Prepaid income taxes |
|
|
|||||||||
Other current assets |
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property and equipment, net |
|
|
|||||||||
Operating lease right-of-use assets |
|
|
|||||||||
Other assets |
|
|
|||||||||
Total assets | $ |
|
|
||||||||
Liabilities and Stockholders' Equity | |||||||||||
Current liabilities: | |||||||||||
Current portion of debt | $ |
|
|
||||||||
Accounts payable |
|
|
|||||||||
Accrued expenses |
|
|
|||||||||
Current portion of operating lease liabilities |
|
|
|||||||||
Income taxes payable |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-term debt |
|
|
|||||||||
Operating lease liabilities |
|
|
|||||||||
Deferred income taxes |
|
|
|||||||||
Other long-term liabilities |
|
|
|||||||||
Commitments and contingencies (Notes 3, 5, 6, and 8) |
|
|
|||||||||
Stockholders' equity: | |||||||||||
Preferred stock: $
|
|
|
|||||||||
Common stock: $
|
|
|
|||||||||
Additional paid-in capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||
Total stockholders' equity |
|
|
|||||||||
Total liabilities and stockholders' equity | $ |
|
|
Three Months Ended
March 31, |
|||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Net sales | $ |
|
|
||||||||||||||||||||
Cost of sales |
|
|
|||||||||||||||||||||
Gross profit |
|
|
|||||||||||||||||||||
Selling, general, and administrative expenses |
|
|
|||||||||||||||||||||
Operating income |
|
|
|||||||||||||||||||||
Interest income |
|
|
|||||||||||||||||||||
Interest expense |
(
|
(
|
|||||||||||||||||||||
Income before income taxes |
|
|
|||||||||||||||||||||
Income tax expense |
|
|
|||||||||||||||||||||
Net income | $ |
|
|
||||||||||||||||||||
Basic net income per share | $ |
|
|
||||||||||||||||||||
Diluted net income per share | $ |
|
|
||||||||||||||||||||
Basic weighted average shares outstanding |
|
|
|||||||||||||||||||||
Diluted weighted average shares outstanding |
|
|
Three Months Ended
March 31, |
|||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Net income | $ |
|
|
||||||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Foreign currency translation adjustments |
|
(
|
|||||||||||||||||||||
Comprehensive income | $ |
|
|
Three Months Ended
March 31, |
|||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Common stock | |||||||||||||||||||||||
Balance at beginning of period | $ |
|
|
||||||||||||||||||||
Balance at end of period |
|
|
|||||||||||||||||||||
Additional paid-in capital | |||||||||||||||||||||||
Balance at beginning of period |
|
|
|||||||||||||||||||||
Stock options exercised |
|
|
|||||||||||||||||||||
Stock-based compensation |
|
|
|||||||||||||||||||||
Balance at end of period |
|
|
|||||||||||||||||||||
Retained earnings | |||||||||||||||||||||||
Balance at beginning of period |
|
|
|||||||||||||||||||||
Net income |
|
|
|||||||||||||||||||||
Cash dividends paid |
(
|
(
|
|||||||||||||||||||||
Balance at end of period |
|
|
|||||||||||||||||||||
Accumulated other comprehensive income (loss) | |||||||||||||||||||||||
Balance at beginning of period |
(
|
(
|
|||||||||||||||||||||
Other comprehensive income (loss) |
|
(
|
|||||||||||||||||||||
Balance at end of period |
(
|
(
|
|||||||||||||||||||||
Total stockholders' equity | $ |
|
|
||||||||||||||||||||
Cash dividends paid per share of common stock | $ |
|
|
Three Months Ended
March 31, |
|||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ |
|
|
||||||||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||
Depreciation of property and equipment |
|
|
|||||||||||||||||||||
Gain on sale of property and equipment |
(
|
(
|
|||||||||||||||||||||
Bad debt expense (recoveries) |
|
(
|
|||||||||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||||||||
Stock-based compensation |
|
|
|||||||||||||||||||||
Amortization of intangible assets |
|
|
|||||||||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||||||||
Trade accounts receivable |
(
|
(
|
|||||||||||||||||||||
Inventories |
(
|
|
|||||||||||||||||||||
Other current assets |
|
|
|||||||||||||||||||||
Accounts payable |
|
|
|||||||||||||||||||||
Accrued expenses |
(
|
(
|
|||||||||||||||||||||
Income taxes |
|
|
|||||||||||||||||||||
Other |
(
|
|
|||||||||||||||||||||
Net cash provided by operating activities |
|
|
|||||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Purchases of property and equipment |
(
|
(
|
|||||||||||||||||||||
Proceeds from sale of property and equipment |
|
|
|||||||||||||||||||||
Other |
|
(
|
|||||||||||||||||||||
Net cash used in investing activities |
(
|
(
|
|||||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from debt obligations |
|
|
|||||||||||||||||||||
Payments against debt obligations |
(
|
(
|
|||||||||||||||||||||
Proceeds from exercise of stock options |
|
|
|||||||||||||||||||||
Cash dividends paid |
(
|
(
|
|||||||||||||||||||||
Net cash used in financing activities |
(
|
(
|
|||||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
|
(
|
|||||||||||||||||||||
Net (decrease) increase in cash and cash equivalents |
(
|
|
|||||||||||||||||||||
Cash and cash equivalents at beginning of period |
|
|
|||||||||||||||||||||
Cash and cash equivalents at end of period | $ |
|
|
||||||||||||||||||||
Supplemental information: | |||||||||||||||||||||||
Cash paid for interest | $ |
|
|
||||||||||||||||||||
Net cash paid for income taxes | $ |
|
|
||||||||||||||||||||
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities | $ |
|
|
Three-month Period | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
United States | $ |
|
|
||||||||||||||||||||
% of revenues |
|
% |
|
% | |||||||||||||||||||
Canada and Mexico |
|
|
|||||||||||||||||||||
% of revenues |
|
% |
|
% | |||||||||||||||||||
All other foreign countries |
|
|
|||||||||||||||||||||
% of revenues |
|
% |
|
% | |||||||||||||||||||
Total revenues | $ |
|
|
Three-month Period | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Manufacturing |
|
% |
|
% | |||||||||||||||||||
Non-residential construction |
|
% |
|
% | |||||||||||||||||||
Other |
|
% |
|
% | |||||||||||||||||||
|
% |
|
% |
Three-month Period | ||||||||||||||||||||||||||
Type | Introduced | 2025 | 2024 | |||||||||||||||||||||||
Fasteners
(1)
|
1967 |
|
% |
|
% | |||||||||||||||||||||
Tools | 1993 |
|
% |
|
% | |||||||||||||||||||||
Cutting tools | 1996 |
|
% |
|
% | |||||||||||||||||||||
Hydraulics & pneumatics | 1996 |
|
% |
|
% | |||||||||||||||||||||
Material handling | 1996 |
|
% |
|
% | |||||||||||||||||||||
Janitorial supplies | 1996 |
|
% |
|
% | |||||||||||||||||||||
Electrical supplies | 1997 |
|
% |
|
% | |||||||||||||||||||||
Welding supplies | 1997 |
|
% |
|
% | |||||||||||||||||||||
Safety supplies | 1999 |
|
% |
|
% | |||||||||||||||||||||
Other |
|
% |
|
% | ||||||||||||||||||||||
|
% |
|
% |
2025 | 2024 | ||||||||||
First quarter | $ |
|
$ |
|
|||||||
Second quarter |
|
|
|||||||||
Third quarter |
|
||||||||||
Fourth quarter |
|
||||||||||
Total | $ |
|
$ |
|
Options
Granted |
Option Exercise
Price |
Closing Stock Price on Grant Date | March 31, 2025 | ||||||||||||||||||||||||||
Date of Grant |
Options
Outstanding |
Options
Exercisable |
|||||||||||||||||||||||||||
January 2, 2025 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 2, 2024 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 3, 2023 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 3, 2022 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 4, 2021 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 2, 2020 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 2, 2019 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 2, 2018 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
January 3, 2017 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
April 19, 2016 |
|
$ |
|
$ |
|
|
|
||||||||||||||||||||||
Total |
|
|
|
Date of Grant |
Risk-free
Interest Rate |
Expected Life
of Option in Years |
Expected
Dividend Yield |
Expected
Stock Volatility |
Estimated Fair
Value of Stock Option |
||||||||||||||||||||||||
January 2, 2025 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 2, 2024 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 3, 2023 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 3, 2022 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 4, 2021 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 2, 2020 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 2, 2019 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 2, 2018 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
January 3, 2017 |
|
% |
|
|
% |
|
% | $ |
|
||||||||||||||||||||
April 19, 2016 |
|
% |
|
|
% |
|
% | $ |
|
Three-month Period | |||||||||||||||||||||||
Reconciliation | 2025 | 2024 | |||||||||||||||||||||
Basic weighted average shares outstanding |
|
|
|||||||||||||||||||||
Weighted shares assumed upon exercise of stock options |
|
|
|||||||||||||||||||||
Diluted weighted average shares outstanding |
|
|
Three-month Period | |||||||||||||||||||||||
Summary of Anti-dilutive Options Excluded | 2025 | 2024 | |||||||||||||||||||||
Options to purchase shares of common stock |
|
|
|||||||||||||||||||||
Weighted average exercise prices of options | $ |
|
|
Average Interest Rate at March 31, 2025
|
Debt Outstanding | ||||||||||||||||||||||
Maturity
Date |
March 31,
2025 |
December 31,
2024 |
|||||||||||||||||||||
Unsecured revolving credit facility |
|
% | September 28, 2027 | $ |
|
|
|||||||||||||||||
Senior unsecured promissory notes payable, Series D |
|
% | May 15, 2025 |
|
|
||||||||||||||||||
Senior unsecured promissory notes payable, Series E |
|
% | May 15, 2027 |
|
|
||||||||||||||||||
Senior unsecured promissory notes payable, Series G |
|
% | June 24, 2026 |
|
|
||||||||||||||||||
Senior unsecured promissory notes payable, Series H |
|
% | June 24, 2030 |
|
|
||||||||||||||||||
Total |
|
|
|||||||||||||||||||||
Less: Current portion of debt |
(
|
(
|
|||||||||||||||||||||
Long-term debt | $ |
|
|
||||||||||||||||||||
Outstanding letters of credit under unsecured revolving credit facility - contingent obligation | $ |
|
|
Three-month Period | |||||||||||
2025 | 2024 | ||||||||||
U.S. net sales from external customers | $ |
|
|
Three-month Period | |||||||||||
2025 | 2024 | ||||||||||
U.S. ROA pre-tax profit | $ |
|
|
||||||||
Other operating segment pre-tax profit
(1)
|
|
|
|||||||||
Income before income taxes | $ |
|
|
March 31,
2025 |
December 31,
2024 |
||||||||||
U.S. ROA assets
(1)
|
$ |
|
|
Three-month Period | |||||||||||
2025 | 2024 | ||||||||||
U.S. ROA pre-tax profit depreciation and amortization expense | $ |
|
|
Three-month Period | |||||||||||||||||||||||||||||||||||
2025 | 2024 | Change | |||||||||||||||||||||||||||||||||
Net sales | $ | 1,959.4 | 1,895.1 | 3.4 | % | ||||||||||||||||||||||||||||||
Business days | 63 | 64 | |||||||||||||||||||||||||||||||||
Daily sales | $ | 31.1 | 29.6 | 5.0 | % | ||||||||||||||||||||||||||||||
Gross profit | $ | 883.9 | 861.6 | 2.6 | % | ||||||||||||||||||||||||||||||
% of net sales | 45.1 | % | 45.5 | % | |||||||||||||||||||||||||||||||
SG&A expenses | $ | 490.0 | 471.4 | 3.9 | % | ||||||||||||||||||||||||||||||
% of net sales | 25.0 | % | 24.9 | % | |||||||||||||||||||||||||||||||
Operating income | $ | 393.9 | 390.2 | 0.9 | % | ||||||||||||||||||||||||||||||
% of net sales | 20.1 | % | 20.6 | % | |||||||||||||||||||||||||||||||
Income before income taxes | $ | 393.1 | 389.8 | 0.8 | % | ||||||||||||||||||||||||||||||
% of net sales | 20.1 | % | 20.6 | % | |||||||||||||||||||||||||||||||
Net income | $ | 298.7 | 297.7 | 0.3 | % | ||||||||||||||||||||||||||||||
Diluted net income per share | $ | 0.52 | 0.52 | 0.2 | % | ||||||||||||||||||||||||||||||
Note – Daily sales are defined as the total net sales for the period divided by the number of business days (in the U.S.) in the period. |
Change
Since: |
Change
Since: |
|||||||||||||||||||||||||||||||
Q1
2025 |
Q4
2024 |
Q4
2024 |
Q1
2024 |
Q1
2024 |
||||||||||||||||||||||||||||
Selling personnel - absolute employee headcount
(1)
|
16,995 | 16,669 | 2.0 | % | 16,726 | 1.6 | % | |||||||||||||||||||||||||
Selling personnel - FTE employee headcount
(1)
|
15,236 | 15,014 | 1.5 | % | 15,064 | 1.1 | % | |||||||||||||||||||||||||
Total personnel - absolute employee headcount | 24,181 | 23,702 | 2.0 | % | 23,695 | 2.1 | % | |||||||||||||||||||||||||
Total personnel - FTE employee headcount | 21,339 | 20,958 | 1.8 | % | 20,935 | 1.9 | % | |||||||||||||||||||||||||
Number of branch locations | 1,587 | 1,597 | -0.6 | % | 1,592 | -0.3 | % | |||||||||||||||||||||||||
Number of $50K+ customer sites | 2,502 | 2,330 | 7.4 | % | 2,340 | 6.9 | % | |||||||||||||||||||||||||
Weighted FMI devices (MEU installed count) | 129,996 | 126,957 | 2.4 | % | 115,653 | 12.4 | % |
Three-month Period | |||||||||||
2025 | 2024 | ||||||||||
Net sales | 100.0 | % | 100.0 | % | |||||||
Gross profit | 45.1 | % | 45.5 | % | |||||||
SG&A expenses | 25.0 | % | 24.9 | % | |||||||
Operating income | 20.1 | % | 20.6 | % | |||||||
Net interest expense | 0.0 | % | 0.0 | % | |||||||
Income before income taxes | 20.1 | % | 20.6 | % | |||||||
Note – Amounts may not foot due to rounding difference. |
Three-month Period | |||||||||||
2025 | 2024 | ||||||||||
Net sales | $ | 1,959.4 | 1,895.1 | ||||||||
Percentage change | 3.4 | % | 1.9 | % | |||||||
Business days | 63 | 64 | |||||||||
Daily sales | $ | 31.1 | 29.6 | ||||||||
Percentage change | 5.0 | % | 1.9 | % | |||||||
Daily sales impact of currency fluctuations | -0.5 | % | 0.0 | % |
DSR Change
Three-month Period |
% of Sales
Three-month Period |
||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||
OEM fasteners | 3.9 | % | -4.0 | % | 19.4 | % | 19.6 | % | |||||||||
MRO fasteners | -3.3 | % | -5.1 | % | 10.9 | % | 11.9 | % | |||||||||
Total fasteners | 1.1 | % | -4.4 | % | 30.3 | % | 31.5 | % | |||||||||
Safety supplies | 7.1 | % | 8.3 | % | 22.0 | % | 21.6 | % | |||||||||
Other product lines | 6.7 | % | 3.9 | % | 47.7 | % | 46.9 | % | |||||||||
Total non-fasteners | 6.8 | % | 5.2 | % | 69.7 | % | 68.5 | % |
DSR Change
Three-month Period |
% of Sales
Three-month Period |
||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||
Heavy manufacturing | 4.8 | % | 2.7 | % | 43.4 | % | 43.4 | % | |||||||||
Other manufacturing | 9.7 | % | 2.5 | % | 33.0 | % | 31.6 | % | |||||||||
Total manufacturing | 6.8 | % | 2.6 | % | 76.4 | % | 75.0 | % | |||||||||
Non-residential construction | -3.4 | % | -6.6 | % | 7.8 | % | 8.5 | % | |||||||||
Other end markets | 0.8 | % | 3.9 | % | 15.8 | % | 16.5 | % | |||||||||
Total non-manufacturing | -0.6 | % | 0.0 | % | 23.6 | % | 25.0 | % |
DSR Change
Three-month Period |
% of Sales
Three-month Period |
||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||
Contract sales | 8.5 | % | 7.2 | % | 73.1 | % | 70.6 | % | |||||||||
Non-contract sales | -3.6 | % | -8.8 | % | 26.9 | % | 29.4 | % |
Three-month period
2025 |
Three-month period
2024 |
||||||||||||||||||||||
Customer Sites (#)
(1) (2)
|
Sales |
Mo. Sales per Customer Site
(3)
|
Customer Sites (#)
(1) (2)
|
Sales |
Mo. Sales per Customer Site
(3)
|
||||||||||||||||||
Manufacturing | |||||||||||||||||||||||
$50K+/Mo.
(4)
|
2,114 | $ | 874.0 | $ | 137,811 | 1,987 | $ | 819.2 | $ | 137,427 | |||||||||||||
$10K+/Mo. | 8,500 | 1,293.1 | 50,710 | 8,263 | 1,230.0 | 49,619 | |||||||||||||||||
$5K-$10K/Mo. | 4,451 | 95.5 | 7,152 | 4,448 | 95.3 | 7,142 | |||||||||||||||||
<$5K/Mo. | 30,308 | 101.7 | 1,119 | 31,999 | 104.7 | 1,091 | |||||||||||||||||
Other sales
(5)
|
— | 2.7 | — | — | 11.1 | — | |||||||||||||||||
Total manufacturing sales | 43,259 | $ | 1,493.0 | $ | 11,484 | 44,710 | $ | 1,441.1 | $ | 10,661 | |||||||||||||
Non-manufacturing | |||||||||||||||||||||||
$50K+/Mo.
(4)
|
388 | $ | 136.6 | $ | 117,354 | 353 | $ | 116.0 | $ | 109,537 | |||||||||||||
$10K+/Mo. | 2,918 | 288.5 | 32,956 | 2,890 | 265.7 | 30,646 | |||||||||||||||||
$5K-$10K/Mo. | 2,749 | 58.2 | 7,057 | 2,888 | 60.8 | 7,018 | |||||||||||||||||
<$5K/Mo. | 52,118 | 109.7 | 702 | 59,156 | 116.3 | 655 | |||||||||||||||||
Other sales
(5)
|
— | 10.0 | — | — | 11.2 | — | |||||||||||||||||
Total non-manufacturing sales | 57,785 | $ | 466.4 | $ | 2,633 | 64,934 | $ | 454.0 | $ | 2,273 | |||||||||||||
Total | |||||||||||||||||||||||
$50K+/Mo.
(4)
|
2,502 | $ | 1,010.6 | $ | 134,639 | 2,340 | $ | 935.1 | $ | 133,205 | |||||||||||||
$10K+/Mo. | 11,418 | 1,581.6 | 46,173 | 11,153 | 1,495.7 | 44,702 | |||||||||||||||||
$5K-$10K/Mo. | 7,200 | 153.8 | 7,120 | 7,336 | 156.2 | 7,097 | |||||||||||||||||
<$5K/Mo. | 82,426 | 211.4 | 855 | 91,155 | 221.0 | 808 | |||||||||||||||||
Other sales
(5)
|
— | 12.6 | — | — | 22.2 | — | |||||||||||||||||
Total net sales | 101,044 | $ | 1,959.4 | $ | 6,422 | 109,644 | $ | 1,895.1 | $ | 5,694 |
Three-month Period | |||||||||||||||||
2025 | 2024 |
DSR
Change
(3)
|
|||||||||||||||
Weighted FASTBin/FASTVend signings (MEUs) | 6,418 | 6,726 | -4.6 | % | |||||||||||||
Signings per day | 102 | 105 | |||||||||||||||
Weighted FASTBin/FASTVend installations (MEUs; end of period) | 129,996 | 115,653 | 12.4 | % | |||||||||||||
FASTStock sales | $ | 239.1 | 239.8 | 1.3 | % | ||||||||||||
% of sales | 12.1 | % | 12.5 | % | |||||||||||||
FASTBin/FASTVend sales | $ | 619.9 | 556.9 | 13.1 | % | ||||||||||||
% of sales | 31.3 | % | 29.0 | % | |||||||||||||
FMI sales | $ | 859.0 | 796.7 | 9.5 | % | ||||||||||||
FMI daily sales | $ | 13.6 | 12.4 | ||||||||||||||
% of sales | 43.3 | % | 41.5 | % | |||||||||||||
eBusiness sales | $ | 607.6 | 549.3 | 12.9 | % | ||||||||||||
% of sales | 30.7 | % | 28.6 | % | |||||||||||||
Less: eBusiness and FMI sales overlap | $ | 258.6 | 210.6 | 24.8 | % | ||||||||||||
% of sales | 13.1 | % | 11.0 | % | |||||||||||||
Digital Footprint sales | $ | 1,208.0 | 1,135.4 | 8.3 | % | ||||||||||||
% of sales | 61.0 | % | 59.2 | % |
Approximate Percentage of Total SG&A Expenses | Three-month Period | |||||||
2025 | ||||||||
Employee-related expenses | 70% to 75% | 2.3 | % | |||||
Occupancy-related expenses | 15% to 20% | 6.3 | % | |||||
All other SG&A expenses | 10% to 15% | 10.4 | % |
Change
Since: |
Change
Since: |
|||||||||||||||||||
Q1
2025 |
Q4
2024
(1)
|
Q4
2024 |
Q1
2024
(1)
|
Q1
2024 |
||||||||||||||||
Selling personnel
(2)
|
15,236 | 15,014 | 1.5 | % | 15,064 | 1.1 | % | |||||||||||||
Distribution/Transportation personnel | 3,111 | 2,997 | 3.8 | % | 3,013 | 3.3 | % | |||||||||||||
Manufacturing personnel | 957 | 936 | 2.2 | % | 888 | 7.8 | % | |||||||||||||
Organizational support personnel
(3)
|
2,035 | 2,011 | 1.2 | % | 1,970 | 3.3 | % | |||||||||||||
Total personnel | 21,339 | 20,958 | 1.8 | % | 20,935 | 1.9 | % |
(1)
|
In the fourth quarter of 2024, we realigned certain employees as a result of a routine review of our organizational structure. While there is no change to total absolute or total FTE headcount, it produces minor shifts between headcount categories. Historical numbers have been adjusted to reflect this realignment.
|
||||
(2)
|
Of our Selling Personnel, 80%-85% are attached to a specific in-market location.
|
||||
(3)
|
Organizational support personnel consists of: (1) Sales Support personnel (37% to 42% of category), which includes sourcing, purchasing, supply chain, product development, etc.; (2) information technology (IT) personnel (35% to 40% of category); and (3) Administrative Support personnel (22% to 27% of category), which includes human resources, Fastenal School of Business, accounting and finance, senior management, etc.
|
Three-month Period | |||||||||||||||||
2025 | 2024 | Change | |||||||||||||||
Net cash provided by operating activities | $ | 262.2 | 335.6 | -21.8 | % | ||||||||||||
% of net income | 87.8 | % | 112.7 | % | |||||||||||||
Net cash used in investing activities | $ | 53.8 | 48.4 | 11.3 | % | ||||||||||||
% of net income | 18.0 | % | 16.3 | % | |||||||||||||
Net cash used in financing activities | $ | 235.5 | 267.4 | -11.9 | % |
March 31 | Twelve-month Dollar Change | Twelve-month Percentage Change | ||||||||||||||||||||||||
2025 | 2024 | 2025 | 2025 | |||||||||||||||||||||||
Accounts receivable, net | $ | 1,278.7 | 1,213.2 | $ | 65.5 | 5.4 | % | |||||||||||||||||||
Inventories | 1,673.9 | 1,496.3 | 177.5 | 11.9 | % | |||||||||||||||||||||
Trade working capital | $ | 2,952.6 | 2,709.5 | $ | 243.0 | 9.0 | % | |||||||||||||||||||
Accounts payable | $ | 341.1 | 276.0 | $ | 65.1 | 23.6 | % | |||||||||||||||||||
Trade working capital, net | $ | 2,611.5 | 2,433.5 | $ | 177.9 | 7.3 | % | |||||||||||||||||||
Net sales in last three months | $ | 1,959.4 | 1,895.1 | $ | 64.3 | 3.4 | % |
Period |
Total Number of
Shares Purchased |
Average Price
Paid per Share |
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
(1)
|
Maximum Number (or
Approximate Dollar
Value) of Shares that
May Yet Be Purchased
Under the Plans or
Programs
(1)
|
||||||||||||||||||||||||||||||||||
January 1-31, 2025 | 0 | $0.00 | 0 | 6,200,000 | ||||||||||||||||||||||||||||||||||
February 1-28, 2025 | 0 | $0.00 | 0 | 6,200,000 | ||||||||||||||||||||||||||||||||||
March 1-31, 2025 | 0 | $0.00 | 0 | 6,200,000 | ||||||||||||||||||||||||||||||||||
Total | 0 | $0.00 | 0 | 6,200,000 |
(1)
|
As of March 31, 2025, we had remaining authority to repurchase 6,200,000 shares of our common stock under the July 12, 2022 authorization, which originally authorized the repurchase of up to 8,000,000 shares. This authorization does not have an expiration date.
|
Exhibit Number | Description of Document | |||||||
3.1 | ||||||||
3.2 | ||||||||
31 | ||||||||
32 | ||||||||
101 |
The following information from the quarterly report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, (vi) Notes to Condensed Consolidated Financial Statements, and (vii) the information set forth in Part II, Item 5.
|
|||||||
104 |
The cover page from the quarterly report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL.
|
|||||||
FASTENAL COMPANY | |||||||||||
Date: April 16, 2025 | By: | /s/ Holden Lewis | |||||||||
Holden Lewis | |||||||||||
Senior Executive Vice President and Chief Financial Officer | |||||||||||
(Principal Financial Officer) | |||||||||||
Date: April 16, 2025 | By: | /s/ Sheryl A. Lisowski | |||||||||
Sheryl A. Lisowski | |||||||||||
Executive Vice President - Chief Accounting Officer and Treasurer | |||||||||||
(Duly Authorized Officer and Principal Accounting Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Wayne A. I. Frederick, M.D. was initially elected to the Board in February 2020. He is the President Emeritus of Howard University, having previously served as the 17th President from July 2014 -September 2023, and is the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine. He is also a practicing cancer surgeon at Howard University Hospital. Prior to that Dr. Frederick served as Howard University’s Interim President (elected October 2013) after serving as Provost and Chief Academic Officer for more than a year. | |||
Raquel C. Bono, M.D. was initially elected to the Board in September 2020. Dr. Bono is a Principal at RCB Consulting having held this position since October 2019, and serves as CEO and Chief of Surgical Innovation at Medical iSight, having held this position since 2023. Dr. Bono was formerly Chief Health Officer at Viking Cruises from November 2020 until her retirement in December 2023. Prior to Viking Cruises, Dr. Bono, a board-certified trauma surgeon and retired Vice Admiral, U.S. Navy Medical Corps, served as the Chief Executive Officer and Director for the Defense Health Agency (DHA). In this capacity, Dr. Bono led a joint, integrated combat support agency that enables all branches of the U.S. military medical services to provide health care services to combatant commands in times of both peace and war. Dr. Bono integrated an unprecedented $50 billion worldwide health care enterprise for the Army, Navy, Air Force, and Marine Corps, composed of 50 hospitals and 300 clinics that provide care to 9.5 million military personnel, oversaw the Department of Defense deployment of the electronic health record, and facilitated the collaboration between the largest federated health systems of the Department of Defense and Department of Veterans Affairs (VA). An American College of Surgeons (ACS) Fellow since 1991, Dr. Bono served on the ACS Board of Governors and the Governors Health Policy and Advocacy Workgroup. She has been honored with the Defense Distinguished Service Medal, three Defense Superior Service Medals, four Legion of Merit Medals, two Meritorious Service Medals, and two Navy and Marine Corps Commendation medals. | |||
Marcy S. Klevorn was initially elected to the Board in February 2021. Ms. Klevorn was formerly the Chief Transformation Officer of Ford Motor Company from May 2019 until her retirement in October 2019. In this role, she accelerated the company’s transformation by helping to refine its corporate governance systems, facilitate faster adoption of agile teams across the business and ensure process improvements across the enterprise. She also facilitated strategic partnerships with key technology partners and supported the company’s diversity efforts. Having joined Ford Motor Company in 1983, Ms. Klevorn served in key executive and leadership roles within the company’s information technology organization including Director of the Office of the Chief Information Officer and Group Vice President of Information Technology. Ms. Klevorn also served as Executive Vice President and President of Ford Smart Mobility LLC, a division of Ford Motor Company, where she oversaw certain acquisitions and other investments and helped to accelerate the company’s plans to design, build, grow and invest in emerging mobility services and global data insight and analytics. | |||
Kurt J. Hilzinger was initially elected to the Board in July 2003 and was elected Chairman of the Board effective January 1, 2014. Mr. Hilzinger served as Lead Director from August 2010 until his appointment as Chairman. Mr. Hilzinger is a Partner at Court Square Capital Partners (Court Square), an independent private equity firm, having held this position since November 2007. At Court Square, Mr. Hilzinger focuses principally on investments in the healthcare industry. | |||
Karen W. Katz, M.B.A. was initially elected to the Board in September 2019. She was most recently interim CEO of Intermix, LLC from June 2022 to December 2022. Prior to Intermix, Ms. Katz served as the President and CEO of Neiman Marcus Group LTD LLC from 2010 to February 2018. Neiman Marcus Group is an international multibrand omni-channel retailer whose portfolio of brands includes Neiman Marcus, Bergdorf Goodman and MyTheresa. Having joined Neiman Marcus in 1985, Ms. Katz served in key executive and leadership roles in the company’s merchant, stores and eCommerce organizations as Executive Vice President—Stores, a member of the Office of the Chairman of Neiman Marcus Group, and President, Neiman Marcus Online, and President and CEO, Neiman Marcus Stores. | |||
Jorge S. Mesquita was initially elected to the Board in February 2021. Mr. Mesquita was formerly Chief Executive Officer of BlueTriton Brands, from July 2021 until March 2022. In this role Mr. Mesquita led the company’s initiatives to expand market leadership, advance commitment to sustainability and environmental stewardship and to realize the potential of the company’s portfolio of water brands. | |||
John W. Garratt was initially elected to the Board in February 2020. He was formerly the President and Chief Financial Officer of Dollar General Corporation, having held this position from September 2022 to June 2023. Mr. Garratt joined Dollar General in October 2014 as Senior Vice President, Finance & Strategy and subsequently served as Interim Chief Financial Officer from July 2015 to December 2015 and most recently served as Executive Vice President and Chief Financial Officer from December 2015 to September 1, 2022. Prior to joining Dollar General, Mr. Garratt held various positions of increasing responsibility with Yum! Brands, Inc., one of the world’s largest restaurant companies, between May 2004 and October 2014, holding leadership positions in corporate strategy and financial planning. Mr. Garratt served as Vice President, Finance and Division Controller for the KFC division and earlier for the Pizza Hut division and for Yum Restaurants International between October 2013 and October 2014. Mr. Garratt also served as the Senior Director, Yum Corporate Strategy, from March 2010 to October 2013, reporting directly to the corporate Chief Financial Officer and leading corporate strategy as well as driving key cross-divisional initiatives. Mr. Garratt served in various other financial positions at Yum from May 2004 to March 2010. Prior to his career at Yum! Brands, Mr. Garratt served as Plant Controller for Alcoa Inc. between April 2002 and May 2004, and held various financial management positions at General Electric from March 1999 to April 2002. He began his career in May 1990 at Alcoa, where he served for approximately nine years. | |||
James A. Rechtin Director, President and Chief Executive Officer, and Stockholder March 7, 2025 | |||
Gordon Smith was initially elected to the Board in October 2024. Mr. Smith was formerly the Co-President and Co-Chief Operating Officer of JPMorgan Chase & Co. (JPMorgan), having held these positions from 2018 until retiring in January of 2022. In this role, Mr. Smith served as a member of the firm’s Operating Committee and helped oversee all aspects of the company’s business and operations. Mr. Smith’s career at JPMorgan began in 2007 and spanned 15 years, where he previously served as Chief Executive Officer of Consumer & Community Banking (2012-2021), and prior to that held various roles of increasing responsibility, including as CEO of Chase Card Services, Auto Finance and Student Lending (2011-2012), and CEO of Chase Card Services (2007-2011). Prior to his time at JPMorgan, Mr. Smith spent more than 25 years at American Express, where he led and managed several businesses, including the Global Commercial Card Business. Mr. Smith is also an operating advisor to Clayton Dubilier & Rice. | |||
The Board believes that Mr. D’Amelio’s skills, global experience and proven leadership in both financial and operational roles contribute greatly to the Board’s composition. As a senior executive at various global companies undergoing the kind of rapid and complex changes that the Company has undertaken in response to the rapidly changing markets and regulatory environment, Mr. D’Amelio has extensive knowledge of the capital markets as well as broad experience working with the investment community, regulatory bodies and rating agencies. | |||
David T. Feinberg, M.D. was initially elected to the Board in March 2022. Dr. Feinberg is Chairman of Oracle Health, where he is committed to making healthcare more accessible, affordable, and equitable. His work advances thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem. Previously, Dr. Feinberg served as President and Chief Executive Officer and member of the Board of Directors of Cerner Corporation (Cerner), which is now Oracle Health. In that role Dr. Feinberg focused on delivering tools and technology to help caregivers optimize the health of their patients and communities. |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Stock Awards ($) |
Option Awards ($) |
Non-Equity Incentive Plan
Compensation
|
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||||||||||||||||||||||||||
James A. Rechtin
|
2024 | 1,105,769 | — | 7,317,483 | 4,495,979 | 1,943,477 | — | 716,768 | 15,579,476 | ||||||||||||||||||||||||||||||||||||
Bruce D. Broussard
|
2024 | 1,344,231 | — | 8,000,037 | 0 | 2,491,803 | — | 221,093 | 12,057,164 | ||||||||||||||||||||||||||||||||||||
2023 | 1,469,893 | — | 10,898,833 | 3,492,874 | — | — | 465,784 | 16,327,384 | |||||||||||||||||||||||||||||||||||||
2022 | 1,349,465 | — | 9,638,547 | 2,785,410 | 3,072,394 | — | 353,028 | 17,198,844 | |||||||||||||||||||||||||||||||||||||
Susan M. Diamond
|
2024 | 846,192 | — | 6,733,897 | 948,087 | 911,377 | — | 177,961 | 9,617,514 | ||||||||||||||||||||||||||||||||||||
2023 | 790,000 | — | 2,802,776 | 898,145 | — | — | 239,812 | 4,730,733 | |||||||||||||||||||||||||||||||||||||
2022 | 750,000 | — | 2,258,317 | 652,754 | 975,750 | — | 174,177 | 4,810,998 | |||||||||||||||||||||||||||||||||||||
David E. Dintenfass
|
2024 | 605,769 | 5,684,000 | 6,084,670 | 4,877,489 | 601,407 | — | 208,222 | 18,061,557 | ||||||||||||||||||||||||||||||||||||
Sanjay K. Shetty, M.D.
|
2024 | 694,808 | 550,000 | 3,798,420 | 623,769 | 661,107 | — | 107,159 | 6,435,263 | ||||||||||||||||||||||||||||||||||||
2023 | 493,269 | 1,400,000 | 1,401,072 | 449,844 | — | — | 837,756 | 4,581,941 | |||||||||||||||||||||||||||||||||||||
George Renaudin II
|
2024 | 717,885 | — | 3,906,380 | 661,165 | 756,626 | — | 110,025 | 6,152,081 | ||||||||||||||||||||||||||||||||||||
2023 | 655,000 | — | 1,712,892 | 548,910 | — | — | 135,676 | 3,052,478 |
Customers
Customer name | Ticker |
---|---|
Target Corporation | TGT |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
BROUSSARD BRUCE D | - | 85,130 | 25,000 |
Mellet Celeste | - | 29,676 | 0 |
Diamond Susan M | - | 19,960 | 2,179 |
HILZINGER KURT J | - | 19,448 | 0 |
Ventura Joseph C | - | 17,267 | 264 |
Renaudin George II | - | 15,702 | 512 |
Fleming William Kevin | - | 11,723 | 121 |
Shetty Sanjay K | - | 7,317 | 0 |
Mehta Japan | - | 5,046 | 0 |
Huval Timothy S. | - | 4,368 | 0 |
Wheatley Timothy Alan | - | 3,983 | 1,025 |
Schick Susan D. | - | 3,687 | 0 |
Diamond Susan M | - | 3,131 | 2,145 |
Renaudin George II | - | 1,547 | 482 |
Smith Gordon | - | 765 | 0 |
Feinberg David T | - | 441 | 0 |
SMITH BRAD D | - | 386 | 0 |
JONES DAVID A JR/KY | - | 380 | 32,440 |
Felter John-Paul W. | - | 145 | 0 |
OBRIEN JAMES J /KY | - | 0 | 1,794 |
Mesquita Jorge S. | - | 0 | 3,361 |
Rechtin James A. | - | 0 | 30,474 |
DAMELIO FRANK A | - | 0 | 20,634 |
McDonald William J. | - | 0 | 2,276 |